SeaStar Medical (NASDAQ:ICU – Get Free Report) and Aethlon Medical (NASDAQ:AEMD – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, risk, institutional ownership, earnings and analyst recommendations.
Insider and Institutional Ownership
1.7% of SeaStar Medical shares are owned by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are owned by institutional investors. 2.1% of SeaStar Medical shares are owned by insiders. Comparatively, 1.1% of Aethlon Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Profitability
This table compares SeaStar Medical and Aethlon Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| SeaStar Medical | N/A | N/A | -627.49% |
| Aethlon Medical | N/A | -160.36% | -115.74% |
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| SeaStar Medical | 0 | 0 | 0 | 0 | 0.00 |
| Aethlon Medical | 0 | 0 | 1 | 0 | 3.00 |
Aethlon Medical has a consensus target price of $7.00, indicating a potential upside of 1,110.03%. Given Aethlon Medical’s stronger consensus rating and higher probable upside, analysts plainly believe Aethlon Medical is more favorable than SeaStar Medical.
Earnings and Valuation
This table compares SeaStar Medical and Aethlon Medical”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| SeaStar Medical | $68,000.00 | 136.52 | -$26.23 million | ($11.63) | -0.18 |
| Aethlon Medical | $570,000.00 | 14.17 | -$12.21 million | ($2.82) | -0.21 |
Aethlon Medical has higher revenue and earnings than SeaStar Medical. Aethlon Medical is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.
Volatility and Risk
SeaStar Medical has a beta of -1.13, meaning that its stock price is 213% less volatile than the S&P 500. Comparatively, Aethlon Medical has a beta of 1.79, meaning that its stock price is 79% more volatile than the S&P 500.
Summary
Aethlon Medical beats SeaStar Medical on 9 of the 13 factors compared between the two stocks.
About SeaStar Medical
SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.
About Aethlon Medical
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.
Receive News & Ratings for SeaStar Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaStar Medical and related companies with MarketBeat.com's FREE daily email newsletter.
